Recommendations for the management of patients with chronic obstructive pulmonary disease (COPD) at primary and specialist pulmonary levels in Slovenia

Authors

  • Sabina Škrgat Univerzitetna klinika za pljučne bolezni in alergijo Golnik
  • Nadja Triller Zdravstveni dom Murska Sobota, Dispanzer za pljučne bolezni in tuberkulozo
  • Mitja Košnik Univerzitetna klinika za pljučne bolezni in alergijo Golnik
  • Tonka Poplas Susič Zdravstveni dom Ljubljana
  • Davorina Petek Zdravstveni zavod Zdravje Ljubljana
  • Vlasta Vodopivec Jamšek Zdravstveni dom Nova Gorica
  • Irena Hudoklin Ambulanta za pljučne bolezni in alergije Trebnje
  • Ana Ogrič Lapajne Zdravstveni dom Idrija, Internistična ambulanta
  • Saša Letonja Zdravstveni dom Jesenice, Pnevmološko alergološka ambulanta
  • Jure Šorli Bolnišnica Topolšica
  • Irma Rozman Sinur Splošna bolnišnica Novo mesto, Pljučni oddelek
  • Marjan Koterle Pulmomed, zasebni zdravstveni zavod Koper
  • Natalija Edelbaher Univerzitetni klinični center Maribor, Oddelek za pljučne bolezni
  • Jurij Regvat Univerzitetni klinični center Maribor, Oddelek za pljučne bolezni
  • Damjan Birtič Splošna bolnišnica »Dr. Franca Derganca« Nova Gorica, Pulmološki oddelek
  • Simona Slaček Splošna bolnišnica Murska Sobota, Pljučni oddelek
  • Mihaela Zidarn Univerzitetna klinika za pljučne bolezni in alergijo Golnik
  • Katja Triller Splošna bolnišnica Izola, Interni oddelek
  • Matjaž Turel Univerzitetni klinični center Ljubljana, Klinični oddelek za pljučne bolezni in alergijo
  • Katarina Osolnik Univerzitetna klinika za pljučne bolezni in alergijo Golnik
  • Robert Marčun Univerzitetna klinika za pljučne bolezni in alergijo Golnik
  • Matjaž Fležar Univerzitetna klinika za pljučne bolezni in alergijo Golnik

DOI:

https://doi.org/10.6016/ZdravVestn.2471

Keywords:

chronic obstructive pulmonary disease (COPD), recommendations, treatment, diagnosis, COPD exacerbation

Abstract

The purpose of this paper is to implement the guidelines proposed by GOLD in the Slovenian healthcare system, and to describe the cornerstones of the management of this disease. Te document is meant to serve as an agreed approach to the management of COPD patients.

Downloads

Download data is not yet available.

References

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseases 2017 report[cited 4.12.2016]. Available from: http://www.goldcopd.com/.

Šuškovič S, Košnik M. Nove smernice za trajno zdravljenje KOPB. Zdrav Vestn. 2013;82(7):530–532.

Šarc I, Jeric T, Ziherl K, Šuškovič S, Košnik M, Anker SD, et. al. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. J Eval Clin Pract. 2011 Aug;17(4):737–43.

World Health Report 2000 [cited 17.5.2016]. Available from: http://www.who.int/whr/2000/en.

Carpenter G, Bernabei R, Hirdes J. Building evidence on chronic disease in old age. BMJ. 2003;32(7234):528–9.

Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Pride D,et al. Question for COPD diagnostic screening in a primary care setting. Respir Med. 2005;99(10):1311–8.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Resp J. 2005 26(2):319–338.

Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Ofcial Statement of the European Respiratory Society. Eur Respir. 1993;16 Suppl 6:5–40.

van Dijk W, Tan W, Li P, Guo B, Li S, Benedetti A, et al. Clinical relevance of fxed ratio vs lower limit of normal of FEV1/FVC in COPD: patient reported outcomes form the canCOLD cohort. Annals of family medicine. 2015;13(1):41–8.

Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, et al. GOLD or lower limit of normal defnition. A comparison with expert based diagnosis of chronic obstructive pulmonary disease in prospective cohort study. Resp Res. 2012;13(1):13.

Lange P, Marrot JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, et al. Prediction of the clinical course of chronic obstrctive pulmonary disease, using the new GOLD classifcation: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–81.

Fleržar M, Šuškovič S, Škrgat K, Košnik M. How to choose and interpret lung function tests in asthma and COPD. Zdrav Vestn. 2011;80(5):337–345.

Marčun R, Suštic A, Brguljan PM, Kadivec S, Farkaš J, Košnik M, et al. Cardiac biomarkers predict outcome afer hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol. 2012 29;161(3):156–9.

Regvat J, Žmitek A, Vegnuti M, Košnik M, Šuškovič S. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2011;39(3):1028–38.

Bateman ED, Reddel HK, van Zyl–Smit RN, Agusti A. Te asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet 2015;3:719–728.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish Guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 2014;50(Suppl 1):1–16.

Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, Zak J, et al. Chronic obstructive pulmonary disease: ofcial diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013;157(2):189–201.

Anthoniesen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. Te effects of a smoking cessation intervention on 14.5-year mortality: a randomised clinical trial. Ann Intern Med 2005;142(4):233–9.

Lee PN, Fry JS. Systematic reviw of the evidence relating FEV1 decline to giving up smoking. BMC Med 2010;8:84.

Wedzicha JA, banerji D, Chapman KR,Vestbo J, Roche N, Ayers RT, et al. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. NEJM 2016;374(23):2222-34.

Ferguson GT, Fležar M, Korn S, Korducki L, Grönke L, Abrahams R, et al. Efcacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis. Adv Ter. 2015;32(6):523–36.

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E. Tiotropium and olodaterol fxed-dose combination versus mono-components in COPD (GOLD 2–4). Eur Respir J. 2015;45(4):969–79.

Fležar M, Jahnz-Różyk K, Enache G, Martynenko T, Kristufek P, Škrinjarić-Cincar S, et al. SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe. Int J Chron Obstruct Pulmon Dis. 2013;8:483–92.

Poplas Susič T, Švab I, Kersnik J. Projekt referenčnih ambulant v Sloveniji. Zdrav Vestn 2013;82(10):635–47.

Benedik B, Farkas J, Kosnik M, Kadivec S, Lainscak M. Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary disease. Respir Med. 2011;105 Suppl 1:S38–43.

Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, Kosnik M, Anker SD, Suskovic S. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011;2(2):81–86.

Gryparis A, Forsberg B, Katsouyanni K, Analitis A, Touloumi G, Schwartz J, Samoli E, Medina S, Anderson HR, Niciu EM, Wichmann HE, Kriz B, Kosnik M, Skorkovsky J, Vonk JM, Dörtbudak Z. Acute effects of ozone on mortality from the “air pollution and health: a European approach” project. Am J Respir Crit Care Med. 2004;170(10):1080–7.

Škrgat S, Šifrer F, Kopčavar Guček N, Osolnik K, Eržen R, et al. Stališče do obravnave akutnega poslabšanja KOPB. Zdrav Vestn. 2009;78(1):19–32.

Lainščak M, Kadivec S, Košnik M, Benedik B, Bratkovic M, Jakhel T, et al. Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. J Am Med Dir Assoc. 2013;14(6):450.e1–6.

Geršak K, Fras Z, Rems M. Ali vemo, kakšne morajo biti dobre klinične smernice? Zdrav Vestn. 2016;85(1):6–14.

Fras Z, Robida A, Brubnjak-Jevtič V, Rems M, Jug B, Kersnik J, et al. Priročnik za smernice. Ljubljana: Ministrstvo za zdravje; 2003. p. 1–32.

Harbour R, Miller J, Scottish Intercollegiate Guidelines Network Grading Review Group. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334-6.

Scottish Intercollegiate Guidelines Network. SIGN grading system 1999–2012. Edinburgh: Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland; National Academy Press; 2014 [cited 2016 May 1]. Available from: http://www.sign.ac.uk/guidelines/fulltext/50/annexoldb.html

Downloads

Published

2017-03-01

Issue

Vol. 86 No. 1-2 (2017): January-February

Section

Professional Article

License


The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence. 

How to Cite

1.
Recommendations for the management of patients with chronic obstructive pulmonary disease (COPD) at primary and specialist pulmonary levels in Slovenia. ZdravVestn [Internet]. 2017 Mar. 1 [cited 2024 Nov. 2];86(1-2):65-7. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2471

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>